a16z invests in Boltz as paying molecular token usage grows 50x since June
GabriCorso · x · 2026-11-18
a16z announced its investment in Boltz, calling it the world's most widely adopted molecular models company. A chart shows molecular tokens processed for paying customers grew 50x from the June 16 baseline to November, accelerating after the BoltzMol-1 and BoltzProt-1 launches. a16z frames AI-driven molecular design, building on AlphaFold, as a fundamentally cheaper path to drug discovery.
Related event: AI drug design startup Boltz raises $110M Series A as usage surges 50x(10 posts)→
More from Venture
- Perplexity turns Anthropic's S-1 into an interactive 3D-chart explainer — jeffgrimes9 · 2026-11-18
- "Boltz is a biotech exponential" — molecular tokens up 50x since June — GabriCorso · 2026-11-18
- Boltz, the AI lab that moved from MIT to the UK, raises $110M — GabriCorso · 2026-11-18
- 49% of CIOs over token budget: Microsoft made AI cost control the product at Ignite — BenBajarin · 2026-11-18
- Industry figures congratulate Boltz on its $110M Series A — GabriCorso · 2026-11-18
- TSMC now demanding cash upfront to secure capacity as AI demand strains supply chain — ctjlewis · 2026-11-18